Literature DB >> 20393248

Neurotoxoplasmosis mimicking intracranial tuberculoma.

V Doraiswamy1, R K Vaswani, K R Lahiri, S S Kondekar.   

Abstract

Neurotoxoplasmosis is a major cause of morbidity and mortality, especially in immunocompromised patients. Definitive diagnosis is invasive and difficult thereby requiring a therapeutic trial. We herein report a case of an 11-year-old boy who presented with a tuberculoma on computerized tomography (CT) brain and did not show any clinical improvement on anti-tuberculous drugs. Subsequently, reviewing the CT scans and with supportive serology, a diagnosis of neurotoxoplasmosis was considered. A trial of antitoxoplasmosis therapy was given to which the child fully responded in two weeks. Three weeks later, his magnetic resonance imaging showed complete resolution of the lesion. This report provides an insight into the significance of therapeutic trial in neurotoxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393248     DOI: 10.4103/0022-3859.62432

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  4 in total

1.  Multiple intracerebral lesions in a young male.

Authors:  Madi Deepak; Achappa Basavaprabhu; Mahalingam Soundarya
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

2.  Intracranial inflammatory granuloma caused by toxoplasmosis.

Authors:  Zhi Hua Li; Fu You Guo; Zhong Quan Wang; Jing Cui
Journal:  Pathog Glob Health       Date:  2014-07       Impact factor: 2.894

3.  Toxoplasmosis with chorioretinitis in an HIV-infected child with no visual complaints-importance of fundus examination.

Authors:  Noella Maria Delia Pereira; Ira Shah; Mamatha Lala
Journal:  Oxf Med Case Reports       Date:  2017-01-03

4.  Audit of computed tomography brain findings in HIV-infected patients with space occupying infective lesions at a regional level hospital in KwaZulu-Natal.

Authors:  Somasundram Pillay; Kaveer Ramchandre
Journal:  SAGE Open Med       Date:  2018-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.